Masimo Corporation (NASDAQ:MASI) has disclosed its preliminary financial results for the second quarter, which ended on June 29, 2024.

The report reflects a robust performance, with consolidated revenues anticipated to reach approximately $496 million.

This figure represents a growth of 9% on a reported basis and 10% on a constant currency basis.

In the healthcare sector, Masimo showed remarkable growth with expected revenues of around $344 million.

This indicates a significant increase of 22% on a reported basis and 23% on a constant currency basis.

Additionally, the company anticipates significant gains from new healthcare contracts, which are expected to add approximately $134 million in incremental value.